Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Yeda Research And Development Co Ltd
Yeda Research And Development Co Ltd At The Weizmann Institute Of Science
Yeda Research And Development Co Ltd At Weizmann Institute Of Science
Yeda Research And Development Co Ltd At The Weizman Institute Of Science
Yeda Research And Development Co Ltd Weizmann Institute Of Science
Yeda Research And Development Co Ltd At The Weizmann Institute Of Sience

Yeda Research And Development Co Ltd patents


Recent patent applications related to Yeda Research And Development Co Ltd. Yeda Research And Development Co Ltd is listed as an Agent/Assignee. Note: Yeda Research And Development Co Ltd may have other listings under different names/spellings. We're not affiliated with Yeda Research And Development Co Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "Y" | Yeda Research And Development Co Ltd-related inventors


 new patent  Methods of treating diseases related to mitochondrial function

Uses of agent which downregulate an activity or expression of a component participating in the mitochondrial apoptotic pathway are disclosed.... Yeda Research And Development Co Ltd

 new patent  Superconducting scanning sensor for nanometer scale temperature imaging

A device and methods for use thereof in low-temperature thermal scanning microscopy, providing non-contact, non-invasive localized temperature and thermal conductivity measurements in nanometer scale ranges with a temperature resolution in the micro-Kelvin order. A superconductive cap mounted on the tip of an elongated support probe is electrically-connected to superconductive leads... Yeda Research And Development Co Ltd

Methods of preventing secondary infections

A method of treating or preventing a disease associated with a secondary infection in a subject infected with a pathogen is provided. The method comprises administering to the subject a therapeutically effective amount of an anti-pathogenic agent directed towards the pathogen and a therapeutically effective amount of an agent which... Yeda Research And Development Co Ltd

Water splitting method and system

An electrode is presented for use in an oxidation process. The electrode comprises a substrate having an electrically conductive surface carrying a chiral system. The chiral system is configured for controlling spin of electrons transferred between the substrate and electrolyte during the oxidation process.... Yeda Research And Development Co Ltd

Nanoscale electronic spin filter

The present invention is in the field of spintronics, and relates to a highly efficient spin filter device, such as a spin-polarizer or a spin valve, and a method for fabrication thereof.... Yeda Research And Development Co Ltd

Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns

The present specification discloses a pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS. The pharmaceutical composition is administered by a dosage regimen comprising at least one course... Yeda Research And Development Co Ltd

Crystal structure of the large ribosomal subunit from s. aureus

A composition-of-matter comprising a crystallized form of a large ribosomal (50S) subunit of a pathogenic bacterium, and the atomic coordinates of the three-dimensional structure thereof are provided herein, as well as methods for crystallizing the same, and using the atomic coordinates of the same to design de novo ligands with... Yeda Research And Development Co Ltd

Method for automatic behavioral phenotyping

A method of identifying and classifying social complex behaviors among a group of model organisms, comprising implanting at least one RFID transponder in each model organism in said group of model organisms; enclosing said group of model organisms in a monitored space divided into RFID monitored segments; RFID tracking a... Yeda Research And Development Co Ltd

Peptides based on the transmembrane domain of a toll-like receptor (tlr) for treatment of tlr-mediated diseases

Peptides are provided that are capable of inhibiting cell activation mediated by a Toll-like receptor (TLR) selected from TLR 1, 2, 4 or 6, said peptide comprising a sequence consisting of, or found within, the sequence of the transmembrane domain of a TLR selected from TLR 1, 2, 4 or... Yeda Research And Development Co Ltd

Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns

A method of generating neural and glial cells is provided. The method comprising growing human stem cells under conditions which induce differentiation of said human stem cells into the neural and glial cells, said conditions comprising the presence of retinoic acid and an agent capable of down-regulating Bone Morphogenic Protein... Yeda Research And Development Co Ltd

Method and system for determining olfactory perception signature

A method of determining olfactory perception signature of a subject is disclosed. The method comprises: providing the subject with a plurality of physical odorant samples for sniffing; for each sniffed odorant sample, presenting to the subject, by a user interface, a set of odorant descriptors and a respective set of... Yeda Research And Development Co Ltd

Treatment of cns inflammatory disorders

A method of upregulating an anti-inflammatory response in a central nervous system (CNS) of a subject in need thereof is disclosed. The method comprising locally administering to the CNS of the subject a therapeutically effective amount of IFN-beta, thereby upregulating the anti-inflammatory response in the CNS of the subject. Methods... Yeda Research And Development Co Ltd

Systems and methods for control, analysis, and/or evaluation of dynamical systems

There is provided a method comprising: receiving a graph comprising nodes with directional edges each associated with a variable weight representing an interaction strength of the respective direction edge adjustable according to a respective range; calculating a current global value defined by a function of the variable weights of the... Yeda Research And Development Co Ltd

Variants of tace pro-domain as tnf-a inhibitor and their medical use

A method of treating an inflammatory disease is disclosed. The method comprises administering to the subject a therapeutically effective amount of a polypeptide comprising a pro-domain of TNF-alpha converting enzyme (TACE), said polypeptide being devoid of a catalytic domain of said TACE, said polypeptide comprising a modification at a site... Yeda Research And Development Co Ltd

Molecular sensor and methods of use thereof

The present invention is directed to fluorescent molecular sensor based on Thiazole Orange for protein detection. interaction of the protein target with the molecular sensors of this invention results in a significant increase in the fluorescence emission. The generation of light output signal enables one to detect protein biomarkers associated... Yeda Research And Development Co Ltd

Anti-her3 antibodies and uses of same

An isolated polypeptide is provided. The isolated polypeptide comprising an antigen recognition domain specifically binding human HER-3 with a KD value of 10 nM or lower, wherein the polypeptide inhibits neuregulin (NRG) binding to the human HERS and NRG-induced cancer cell migration and proliferation.... Yeda Research And Development Co Ltd

Liposomes-containing antifouling compositions and uses thereof

A method of inhibiting adsorption of a biofouling-promoting agent on a surface of a substrate and a method of inhibiting biofilm formation on a surface of a substrate are disclosed herein. The methods comprise comprising contacting the substrate with a composition which comprises liposomes. Further disclosed herein is a composition... Yeda Research And Development Co Ltd

Use of agents for treating fat-related disorders

Use of agents that down-regulates an amount and/or activity of Abelson murine leukemia viral oncogene homolog 1 (c-Abl) or checkpoint kinase 1 (Chk1) in the production of a medicament for treating obesity are disclosed.... Yeda Research And Development Co Ltd

Spin transport electronic device

An electronic device is presented, the device comprises: a spin accumulating structure; a spin selective filter electrically connected at a first end thereof to a first surface of said spin accumulating layer structure; a charge carrier source attached to said spin selective filter at a second end of the spin... Yeda Research And Development Co Ltd

Liquid-organic hydrogen carrier systems based on catalytic peptide formation and hydrogenation

The present invention provides a system and method of storing hydrogen (H2) and releasing it on demand, comprising and making use of diaminoalkanes and alcohols, or aminoalcohols as liquid-organic hydrogen carrier systems (LOHC). 2-amino-ethanol (AE) or its N-methyl derivative 2-(methylamino)ethanol undergo catalytic dehydrogenation to form a cyclic dipeptide (glycine anhydride—GA)... Yeda Research And Development Co Ltd

Ruthenium complexes and their uses as catalysts in processes for formation and/or hydrogenation of esters, amides and related reactions

The present invention relates to novel Ruthenium complexes of formulae A1-A4 and their use, inter alia, for (1) dehydrogenative coupling of alcohols to esters; (2) hydrogenation of esters to alcohols (including hydrogenation of cyclic esters (lactones) or cyclic di-esters (di-lactones), or polyesters); (3) preparing amides from alcohols and amines—(including the... Yeda Research And Development Co Ltd

Use of inhibitory peptides for the treatment of inflammatory diseases

An isolated peptide is disclosed which comprises an amino acid sequence being at least 80% homologous to the sequence as set forth in SEQ ID NO: 1 (PERYQNLSPV), the isolated peptide comprising a nuclear targeting activity, the peptide being no longer than 20 amino acids.... Yeda Research And Development Co Ltd

Magneto-resistance device

This invention relates to structures comprising magnetic materials and conjugated molecules. The invention relates to magneto-resistive devices based on such structures. Structures and devices of the invention can be used as magnetic switches, magnetic sensors and in devices such in/as memory devices.... Yeda Research And Development Co Ltd

Nmda receptor antagonists for treating gaucher disease

The present invention provides pharmaceutical compositions comprising at least one NMDA receptor antagonist for use in treating neuropathic forms of Gaucher Disease (nGD).... Yeda Research And Development Co Ltd

Media for culturing pluripotent stem cells

A culture medium is disclosed which comprises STAT3 activator, an ERK1/2 inhibitor and an Axin stabilizer, and optionally also a PKC inhibitor. Cell cultures comprising same and uses thereof are also disclosed.... Yeda Research And Development Co Ltd

Methods of production of products of metabolic pathways

wherein the first, second and third regulatory sequence are selected such that the expression of the Icy-B and the crtW is greater than a level of expression of the crtI. Methods of generating astaxanthin using the plurality of polynucleotide are also disclosed as well as bacterial cells comprising high levels... Yeda Research And Development Co Ltd

Anti cd84 antibodies, compositions comprising same and uses thereof

Also provided are antibodies comprising antigen recognition domains comprising complementarity determining regions as indicated and uses thereof.... Yeda Research And Development Co Ltd

Blood-brain barrier disrupting agents and uses thereof

The present invention relates to blood-brain barrier disrupting agents containing a modified serum albumin comprising serum albumin. The present invention further relates to pharmaceutical compositions comprising said agents and use thereof for the treatment of brain diseases and disorders.... Yeda Research And Development Co Ltd

Compositions for inhibition of quiescin sulfhydryl oxidase (qsox1) and uses of same

A method of inhibiting or preventing laminin assembly in a basement membrane is disclosed. The method comprising contacting a tissue with an agent which inhibits QSOX1 activity or expression, thereby inhibiting or preventing laminin assembly in the basement membrane.... Yeda Research And Development Co Ltd

Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns

A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS that does not include the autoimmune neuroinflammatory disease, relapsing-remitting multiple sclerosis (RRMS), is provided. The pharmaceutical composition is... Yeda Research And Development Co Ltd

Erk-derived peptides and uses thereof

An isolated peptide being no longer than 20 amino acids comprising a sequence at least 95% homologous to the sequence GQLNHILGILGX1PX2QED (SEQ ID NO: 4), wherein X1 and X2 are any amino acid, the peptide being capable of preventing extracellular signal-regulated kinase1/2 (ERK) translocation into the nucleus.... Yeda Research And Development Co Ltd

Immunotherapy using redirected allogeneic cells

A method of treating a disease, such as cancer, by administering to a subject in need of such treatment an effective amount of allogeneic T cells with a MHC unrestricted chimeric receptor short time after partial lymphodepletion. The method also comprises administering one or more agents that delay egression of... Yeda Research And Development Co Ltd

Antibodies targeted against loxl-2 for the treatment of collagen-associated pathologies

An article of manufacture is disclosed which comprises at least two active agents, wherein a first of the two active agents comprises an anti-cancer agent or an antifibrotic agent and a second of the at least two active agents downregulates the activity and/or expression of lysyl-oxidase like protein-2 (LOXL-2) and... Yeda Research And Development Co Ltd

Method of computational protein design

A method for constructing a library of amino-acid sequences having a common structural fold, and a method for designing and selecting an amino-acid sequence having a desired affinity to a molecular surface of interest of a molecular entity, using the library, are provided herein. The methods are based on a... Yeda Research And Development Co Ltd

Compositions and methods for treating cancer

A method of treating cancer in a subject in need thereof is provided. The method comprising administering to the subject a receptor tyrosine kinase (RTK)-specific cancer therapy and a glucocorticoid or a glucocorticoid analog, such that an efficacy window of said RTK-specific cancer therapy and an efficacy window of said... Yeda Research And Development Co Ltd

06/29/17 / #20170182158

Qsox1 as an anti-neoplastic drug target

The present invention provides methods for tumor treatment by administering an inhibitor of quiescin sulfhydryl oxidase 1 (QSOX1), compositions comprising such inhibitors, and methods for identifying such inhibitors.... Yeda Research And Development Co Ltd

06/29/17 / #20170183665

Recombinant microorganisms capable of carbon fixation

A microorganism which is genetically modified so that it produces a first essential biomass precursor by metabolizing CO2 using a recombinant carbon fixation enzyme is disclosed. The microorganism produces a second biomass precursor by metabolizing an organic carbon source and not by metabolizing CO2. The microorganism does not use the... Yeda Research And Development Co Ltd

06/22/17 / #20170172979

Inhibitors of leukotriene-mediated activity for treating side effects of statin therapy

The present invention relates to the alleviation of adverse side effects resulting from statin therapy. The present invention further relates to the use of an inhibitor of leukotriene C4 (LTC4) mediated activity for alleviating at least one side effects of statin therapy.... Yeda Research And Development Co Ltd

06/22/17 / #20170173573

Copper nanoparticles for degradation of pollutants

The present invention is directed to a degradation composition, methods and kits for degrading organic pollutants comprising reduced copper based nanoparticles-polymer complex (Cu-NPs) and an oxidant.... Yeda Research And Development Co Ltd

06/22/17 / #20170174764

T-cell receptor cdr3 peptides and antibodies

The present invention provides isolated peptides derived from TCR CDR3 segments, antibodies which recognize them, pharmaceutical compositions comprising them and methods of their use for modulating self-immunity.... Yeda Research And Development Co Ltd

06/22/17 / #20170175127

Methods of treating cancer

A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the... Yeda Research And Development Co Ltd

06/15/17 / #20170165285

Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors

A method of preventing tumor metastasis with the proviso that the tumor is not glioma is provided. The method comprising administering to a subject in need thereof a therapeutically effective amount of an inhibitor of synaptojanin 2 (SYNJ2), thereby preventing tumor metastasis. Also, provided is a method of treating cancer.... Yeda Research And Development Co Ltd

05/25/17 / #20170143988

Water soluble anionic bacteriochlorophyll derivatives and their uses

The invention provides anionic water-soluble tetracyclic and pentacyclic bacteriochlorophyll derivatives (Bchls) containing at least one, preferably two or three, negatively charged groups and/or acidic groups that are converted to negatively charged groups at the physiological pH, preferably Bchls having a group COO<−>, COS<−>, SO3<−>, PO3<2−>, COOH, COSH, SO3H, and/or PO3H2... Yeda Research And Development Co Ltd

05/25/17 / #20170145542

Method for platinum group metals recovery from spent catalysts

A method for recovery of platinum group metals from a spent catalyst is described. The method includes crushing the spent catalyst to obtain a catalyst particulate material including particles having a predetermined grain size. The method includes subjecting the catalyst particulate material to a chlorinating treatment in the reaction zone... Yeda Research And Development Co Ltd

05/18/17 / #20170137806

High throughput transcriptome analysis

Kits and methods for single cell or multiple cell transcriptome analysis are provided. An adapter polynucleotide is disclosed which comprises a double-stranded DNA portion of 15 base pairs and no more than 100 base pairs with a 3′single stranded overhang of at least 3 bases and no more than 10... Yeda Research And Development Co Ltd

05/18/17 / #20170141835

Detection of a dispersed pulse signal

A method for detecting a dispersed pulse in a received signal that has been dispersed by a dispersive medium includes obtaining an input army of cells, each indicating an intensity of a frequency component of the signal at a representative time. A fast dispersion measure transform (FDMT) is applied to... Yeda Research And Development Co Ltd

05/11/17 / #20170128365

Surface treatment by water-soluble polymers and lipids/liposomes

A method of reducing a friction coefficient of a surface is disclosed herein, comprising attaching a water-soluble polymer to the surface, and contacting the water-soluble polymer with liposomes, thereby coating the surface with an amphiphilic lipid. Further disclosed herein are solutions comprising a water-soluble polymer attachable to the surface, liposomes,... Yeda Research And Development Co Ltd

05/04/17 / #20170119811

Surface treatment of contact lens and treatment of ocular discomfort by water soluble polymers and lipids/liposomes

Formulations (e.g., solutions) comprising one or more water-soluble polymer(s), liposomes, and an aqueous carrier, are provided. The provided solutions are useful for rinsing, and/or immersing therein, a contact lens and/or in the treatment of ocular discomfort, for example, an ocular discomfort associated with a contact lens. Also provided are kits... Yeda Research And Development Co Ltd

05/04/17 / #20170119847

Short beta-defensin-derived peptides

The invention is directed to β-defensin-derived peptides and their use in modulating the activity of hematopoietic cells, particularly hematopoietic stem cells and progenitor cells. Specifically, the invention provides compositions and methods useful for promoting mobilization and transplantation of hematopoietic stem cells and progenitor cells. The invention further provides compositions and... Yeda Research And Development Co Ltd

05/04/17 / #20170121668

Methods of analyzing cell membranes

A method of precipitating cell membrane fragments from a cell lysate is disclosed. The method comprises contacting the cell lysate with a hydrophobic chelator and a metal ion under conditions that allow precipitation of the cell membrane fragments. Kits for precipitating cell membrane fragments are also disclosed.... Yeda Research And Development Co Ltd

05/04/17 / #20170122950

Antibodies and methods of using same for treating erbb/erbb ligands associated diseases

A method of selecting a target for treatment of a hyperproliferative disease in a subject in need thereof is disclosed. The method comprising analyzing an amount and/or activity of at least one ErbB ligand in a biological sample from the subject, wherein an ErbB ligand which shows an up-regulated amount... Yeda Research And Development Co Ltd

04/20/17 / #20170105645

Electroencephalography with application of transcranial magnetic stimulation

A system includes an array of electroencephalography (EEG) electrodes for placement on the head of a subject and a transcranial magnetic stimulation (TMS) device. A controller is configured to operate the array of EEG electrodes to acquire a plurality of EEG signals concurrently with operation of the TMS device to... Yeda Research And Development Co Ltd

04/20/17 / #20170107251

Novel ruthenium complexes and their uses in processes for formation and/or hydrogenation of esters, amides and derivatives thereof

The present invention relates to novel Ruthenium complexes and related borohydride complexes, and their use for (1) hydrogenation of amides (including polyamides) to alcohols and amines; (2) preparing amides from alcohols with amines (including preparing polyamides (e.g., polypeptides) by reacting dialcohols and diamines or by polymerization of amino alcohols); (3)... Yeda Research And Development Co Ltd

04/13/17 / #20170100037

Multimodal transcranial brain optical imaging

A method of transcranial brain optical imaging including obtaining a Laser Speckle (LS) image of cranial blood vessels of a subject, obtaining a Dynamic Fluorescence (DF) image of the cranial blood vessels of the subject, and combining the LS image and the DF image producing a combined color image which... Yeda Research And Development Co Ltd

03/30/17 / #20170087190

Methods of isolating distinct pancreatic cell types

Methods of isolating distinct specific cell types within mixed populations of cells. Methods of isolating specific cell types among pancreatic cells, particularly from human islets of Langerhans. Markers and combinations thereof for use in methods of isolating insulin producing islet beta cells for treatment of diabetes.... Yeda Research And Development Co Ltd

03/23/17 / #20170081682

Use of enzymes which catalyze pyruvate synthesis from formate and acetyl-coa and bacteria expressing same

Uses of the microorganism and products comprising same are also disclosed.... Yeda Research And Development Co Ltd

03/09/17 / #20170067894

Method and device for detection of pseudomonas aeruginosa

A method of and device for detecting and diagnosing Pseudomonal aeruginosa in a gaseous, liquid or solid sample, employing Lux-R-like receptor-driven reporter cells.... Yeda Research And Development Co Ltd

03/09/17 / #20170069825

Electromechanical effect in metal oxides

This invention provides an electromechanical device comprising an active material comprising a metal oxide such as Ce0.8Gd0.2O1.9 wherein the elastic modulus of metal oxide can be modulated by applying external electric field. The Ce0.8Gd0.2O1.9 layer in a substrate\electrode\Ce0.8Gd0.2O1.9\electrode structure or conductive substrate\Ce0.8Gd0.2O1.9\electrode structure develops a stress upon applying an electric... Yeda Research And Development Co Ltd

03/02/17 / #20170057897

Preparation of aldehydes and ketones from alkenes using polyoxometalate catalysts and nitrogen oxides

The present invention relates to a process for preparing aldehydes and ketones by carbon-carbon bond cleavage of alkenes, wherein the process is catalysed by first row transition metal nitro coordinated polyoxometalate catalyst. The catalyst can be prepared by pre-treatment of aqua coordinated polyoxometalates with NO2, or they are formed in... Yeda Research And Development Co Ltd

02/16/17 / #20170042857

Synaptojanin-2 inhibitors for use in the treatment of cancer

wherein L, X, Y, Z, D, E, i, j and k are as defined herein.... Yeda Research And Development Co Ltd

02/16/17 / #20170045522

Fluorescent molecular sensor for targeting changes in protein surfaces, and methods of use thereof

This invention is directed to monomolecular sensors, comprising a selective binder, a non-selective binder and a fluorophore, which can track changes that occur on the surface of labeled proteins. This invention is further directed to the use of such sensors for identifying binding partners of specific proteins. This invention is... Yeda Research And Development Co Ltd

02/09/17 / #20170037453

Methods and kits for analyzing dna binding moieties attached to dna

(f) analyzing the DNA of the complexes.... Yeda Research And Development Co Ltd

02/02/17 / #20170029508

Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns

The present specification discloses a pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS. The pharmaceutical composition is administered by a dosage regimen comprising at least one course... Yeda Research And Development Co Ltd

02/02/17 / #20170030926

Marker of neuropathic gaucher's disease and methods of use thereof

A biomarker of the neuronopathic types of Gaucher's disease (nGD) is provided, and use thereof for assisting the diagnosis of this form of the disease and its severity. In particular, use of the level of trans-membrane glycoprotein non-metastatic B (GPNMB) or a fragment thereof in the cerebrospinal fluid (CSF) as... Yeda Research And Development Co Ltd

02/02/17 / #20170032079

Stable proteins and methods for designing same

A method for designing and selecting a protein having a stabilized structure compared to a corresponding wild type protein, and proteins having at least six amino acid substitutions with respect to a corresponding wild type protein, designed for improved thermal stability, improved specific activity and/or improved expression levels, are provided... Yeda Research And Development Co Ltd

Patent Packs
01/19/17 / #20170016895

Diagnosis of systemic lupus erythematosus using oligonucleotides antigens

Methods and kits for diagnosing systemic lupus erythematosus (SLE) in a subject are provided. Particularly, the present invention relates to specific oligonucleotide antibody reactivities useful in diagnosing SLE in a subject.... Yeda Research And Development Co Ltd

01/12/17 / #20170009211

Downregulation of mir-7 for promotion of beta cell differentiation and insulin production

A method of ex-vivo increasing insulin content in beta cells or stem cells is disclosed. The method comprising contacting the beta cells or stem cells with an agent for downregulating an activity or expression of miR-7, thereby increasing the insulin content in the beta cells or stem cells.... Yeda Research And Development Co Ltd

01/05/17 / #20170002068

Anti amphiregulin antibodies, compositions comprising same and uses thereof

A method of determining the suitability of a subject to a treatment with an anti-amphiregulin antibody, wherein the subject has a cancer selected from the group consisting of ovarian cancer, head and neck cancer and pancreatic cancer exhibiting resistance to chemotherapy, is provided. The method comprising analyzing in a biological... Yeda Research And Development Co Ltd

01/26/17 / #20170020998

Ceramide levels in the treatment and prevention of infections

The present invention relates to a method for treating or preventing pathogenic infections in a subject having Cystic Fibrosis, COPD, and/or an open wound. This method involves selecting a subject having Cystic Fibrosis, COPD, and/or an open wound and administering to the selected subject a ceramidase under conditions effective to... Yeda Research And Development Co Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Yeda Research And Development Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Yeda Research And Development Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###